Three important FDA debates flared this week https://t.co/LjIOuXCo9e
— The Propell Group (@ThePropellGroup) May 28, 2017
#healthtech
Three important FDA debates flared this week https://t.co/LjIOuXCo9e
— The Propell Group (@ThePropellGroup) May 28, 2017
#healthtech